Curis CRIS
NASDAQ CRIS
$0.40 +0.01 (+2.56%)
At close: Oct 22, 2026 · 4:00 PM EDT

Curis (CRIS) Price to Earnings (2012)

Updated

Curis' (CRIS) Price to Earnings was 164.17 for Q3 2012, down 54.3% from the prior quarter.

Analysis

Curis (CRIS) Price to Earnings (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Curis 779,616.41 -33.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 164.17
Jun 30, 2012 359.52
API Access

Curis Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CRIS&period=max&api_key=YOUR_API_KEY